IGMS IGM Biosciences Inc

Price (delayed)

$94.69

Market cap

$2.91B

P/E Ratio

10

Dividend/share

N/A

EPS

$9.47

Enterprise value

$2.89B

Sector: Healthcare
Industry: Biotechnology

Highlights

The EPS has surged by 116% year-on-year and by 23% since the previous quarter
IGM Biosciences's debt has increased by 24% YoY but it has decreased by 4.6% from the previous quarter
The company's net income has shrunk by 91% YoY and by 16% QoQ
IGM Biosciences's quick ratio has shrunk by 64% YoY and by 23% QoQ

Key stats

What are the main financial stats of IGMS
Market
Shares outstanding
30.7M
Market cap
$2.91B
Enterprise value
$2.89B
Valuations
Price to earnings (P/E)
10
Price to book (P/B)
15.43
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$71.55M
EBITDA
-$68.22M
Free cash flow
-$68M
Per share
EPS
$9.47
Free cash flow per share
-$2.22
Book value per share
$6.14
Revenue per share
$0
TBVPS
$6.91
Balance sheet
Total assets
$211.72M
Total liabilities
$23.54M
Debt
$12.88M
Equity
$188.18M
Working capital
$171.37M
Liquidity
Debt to equity
0.07
Current ratio
13.9
Quick ratio
13.57
Net debt/EBITDA
0.21
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-30.3%
Return on equity
-33.3%
Return on invested capital
-35%
Return on capital employed
-36.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IGMS stock price

How has the IGM Biosciences stock price performed over time
Intraday
-0.89%
1 week
-3.13%
1 month
0.42%
1 year
73.74%
YTD
7.25%
QTD
7.25%

Financial performance

How have IGM Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$74.48M
Net income
-$71.55M
Gross margin
N/A
Net margin
N/A
The operating income has dropped by 98% year-on-year and by 15% since the previous quarter
The company's net income has shrunk by 91% YoY and by 16% QoQ

Growth

What is IGM Biosciences's growth rate over time

Valuation

What is IGM Biosciences stock price valuation
P/E
10
P/B
15.43
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 116% year-on-year and by 23% since the previous quarter
The stock's P/B is 75% above its last 4 quarters average of 8.8
IGM Biosciences's equity has decreased by 26% YoY and by 9% from the previous quarter

Efficiency

How efficient is IGM Biosciences business performance
IGMS's return on equity has dropped by 127% year-on-year and by 26% since the previous quarter
The ROA has plunged by 120% YoY and by 24% from the previous quarter
The return on invested capital rose by 25% year-on-year

Dividends

What is IGMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IGMS.

Financial health

How did IGM Biosciences financials performed over time
IGM Biosciences's current ratio has shrunk by 64% YoY and by 23% QoQ
IGM Biosciences's quick ratio has shrunk by 64% YoY and by 23% QoQ
IGM Biosciences's debt is 93% less than its equity
IGM Biosciences's equity has decreased by 26% YoY and by 9% from the previous quarter
IGM Biosciences's debt has increased by 24% YoY but it has decreased by 4.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.